Increased maternal BMI is associated with infant wheezing in early life: a prospective cohort study

A de Vries1, R M Reynolds1, J R Seckl1

  • 11Endocrinology Unit,University/BHF Centre for Cardiovascular Science,Queen's Medical Research Institute,University of Edinburgh,Edinburgh,UK.

Insights

Maternal obesity before pregnancy is linked to increased wheezing in infants. This association was not explained by maternal cortisol levels, highlighting the need for further research into other maternal factors affecting infant respiratory health.

Area of Science:

  • Reproductive Health
  • Pediatric Health
  • Endocrinology

Background:

  • Rising obesity rates in women of childbearing age pose risks to maternal and infant health.
  • In utero exposure to maternal obesity may influence offspring respiratory development, but underlying mechanisms are unclear.
  • Maternal cortisol levels, altered in obesity, are implicated in offspring wheeze development.

Purpose of the Study:

  • To investigate the association between pre-pregnancy maternal body mass index (BMI) and offspring early life wheezing.
  • To determine if maternal cortisol levels mediate the relationship between maternal BMI and offspring wheezing.

Main Methods:

  • A prospective cohort study (Amsterdam Born Children and their Development cohort) included 4860 women.
  • Data collected via questionnaires on maternal history and offspring wheezing.
  • Pre-pregnancy BMI and maternal serum cortisol levels were measured in subsets of participants.

Main Results:

  • Maternal pre-pregnancy BMI was significantly associated with an increased risk of offspring wheezing (OR: 1.03 per unit increase).
  • Overweight and obese mothers constituted 20.2% of the cohort.
  • Maternal cortisol levels did not mediate the observed association between maternal BMI and offspring wheezing.

Conclusions:

  • Increased pre-pregnancy maternal BMI is a risk factor for wheezing in early childhood.
  • The link between maternal obesity and infant wheezing is not mediated by maternal cortisol levels.
  • Further research is needed to identify other modifiable maternal factors influencing infant wheezing risk.

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...